Atlantic Coastal Acquisition Corp. II (ACABW) Competitors $0.02 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ACABW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, BFRIW, BTMDW, BCTXW, and CALAShould you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. Atlantic Coastal Acquisition Corp. II vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech ARAVIVE Biofrontera biote BriaCell Therapeutics Calithera Biosciences 180 Life Sciences (NASDAQ:ATNFW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment. Which has higher earnings and valuation, ATNFW or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A Is ATNFW or ACABW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Does the media prefer ATNFW or ACABW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Atlantic Coastal Acquisition Corp. II Neutral Summary180 Life Sciences and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks. Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACABW vs. The Competition Export to ExcelMetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$437.73M$6.22B$9.02BDividend YieldN/A5.35%4.18%4.08%P/E RatioN/A0.5413.1720.04Price / SalesN/A514.481,774.08108.84Price / CashN/A178.7349.5328.59Price / BookN/A2.771.915.55Net IncomeN/A-$141.08M$1.23B$248.49M7 Day PerformanceN/A-0.35%0.37%4.87%1 Month PerformanceN/A1.68%3.01%6.63%1 Year PerformanceN/A14.25%15.19%20.38% Atlantic Coastal Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/AN/A$0.00N/A0.0015ATNFW180 Life SciencesN/A$0.01flatN/A-4.6%$0.00N/A0.007Positive NewsGap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/A-80.9%$0.00N/A0.002AIMDWAinosN/A$0.15+15.1%N/AN/A$0.00$106.21K0.0040Gap DownALVOWAlvotechN/A$1.70+13.3%N/A-36.2%$0.00$585.60M0.004Positive NewsARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeBFRIWBiofronteraN/A$0.09-0.1%N/A+157.7%$0.00$38.00M0.0070Positive NewsGap UpBTMDWbioteN/A$0.01-30.2%N/AN/A$0.00$199.38M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.07-0.1%N/A-71.1%$0.00N/A0.008CALACalithera BiosciencesN/A$0.00flatN/A-99.0%$0.00N/A0.0060 Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors ARAVIVE Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Calithera Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACABW) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlantic Coastal Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlantic Coastal Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
